BioPlan Associates

Delivering Actionable Knowledge

China Biopharma Distributors

NEW! Directory: Top 60 Distributors of Bioprocessing Supplies in China: Opportunities for Global Biopharma Suppliers to Find and Manage Local Distributors in China

 

Comprehensive China Biopharmaceutical Equipment and Suppliers Distributors Directory 2020 provides detailed profiles of China’s Equipment and Supply Distributors industry.

Competitive landscape in China’s bioprocess equipment and consumables segment, with comprehensive information on relevant distributors.

Download PDF Brochure

Published by BioPlan Associates, Inc., June 2020
ISBN 978-1-934106-38-9

Hardcover Digital Global License
Order Now Order Now

  

Table of Contents

Highlights

• Best Practices for finding, evaluating, and managing distributors in China
• China’s Emergence in Global Biopharma Manufacturing: Progress and Trends in Chinese Biopharma distribution
• Services in the distribution management and relevant market research services
• Profile Directory of Top Bioprocessing Distributors in China

Topline Findings

  • China mAb Therapeutics expected to grow to USD $26 billion by 2030, with CMOs accessing an increasing share of domestic production.
  • Pipeline Growth in China is accelerating, including markets for mAb therapeutics and vaccines
  • Demand for biologics from domestic developers is increasing at 20% annually

 Table of Contents

  • Chapter 1: Market demands for the high-quality equipment & single-use system
  • Chapter 2: China’s Local Competition Landscape in Upstream, Downstream, Analytical, Assays, Process Development, and Fill Finish
  • Chapter 3: Distribution Situation of Bioprocessing Products in China
  • Chapter 4: Building a Relationship:
    • Case Studies of Collaborations Between China Distributors and Western Vendors
    • Failure Case Studies, Successful Case Studies
    • How to Build a Successful Relationship with Distributors to Advance Your Products in China, Distribution Breadth
  • Chapter 5: Regulatory Environment and Reforms Impacting China Biologics Manufacturing
  • Chapter 6: Top 60 Distributor Company Profiles

Why this Report

  • Assist Western Vendors to gain a deep understanding of the China market
  • Gain basic knowledge about how to start a business in this potentially huge market
  • Readers will learn more about the framework for China distribution
  • Learn how to successfully work with China distributors

 By the Numbers

  • 159 Chinese-owned Equipment Distributors and Suppliers
  • Top 60 Distributors highlighted
  • 100+ pages, 20+ Figures

Download the complete Table of Contents [PDF]

 

In addition, BioPlan’s China Biotech Distributor Strategy Service helps ensure technologies and products are effectively marketed to life sciences companies in China, with a view toward long-term relationship building. The CBD starts with strategic analysis of market opportunities, and includes identification, screening, selection, training, and management of Chinese Distributors. CBD services are offered as modules or complete projects, with emphasis on clear communications and relationship building. Your CBD Team has extensive experience in analyzing and working in the Chinese life sciences market, including in-country presence for real time follow-up.

China CMO

NEW! Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging Opportunities

Comprehensive In-depth Study provides detailed analysis of the CMO industry, its recent development and trends.

Profiles of China’s Contract Manufacturing Organizations (CMOs) and Contract Development Manufacturing Organizations (CDMOs), including their capacity, history, products, scale, management, business focus, products, R&D, business and partnering strategies, strengths and weaknesses, and future objectives.

Download PDF Brochure

Published by BioPlan Associates, Inc., June 2020
ISBN 978-1-934106-39-6

Hardcover Digital Global License
Order Now Order Now

  

Table of Contents [PDF]

Highlights

  • Top Ranked CDMO Facilities in China
  • Trends in the importance of Contract Manufacturing of biologics in China
  • How CMOs are meeting the increased demand and rapid capacity expansions
  • Analysis and Profile Directory of CMOs in China

Topline Findings

  • China mAb Therapeutics expected to grow to USD $26 billion by 2030, with CMOs accessing an increasing share of domestic production.
  • Pipeline Growth in China is accelerating, including markets for mAb therapeutics and vaccines
  • Demand for biologics from domestic developers is increasing at 20% annually

Coverage of Top CMO and CDMO Industry Leaders include:

  • 3S Guojian
  • Asymchem
  • AutekBio
  • Boehringer-Ingelheim Shanghai
  • Canton Bio
  • CC Pharming
  • Celgen Pharma
  • Celltrion
  • Chempartner
  • C-Mab
  • Genescript
  • HJB (Transcenta Holding)
  • Jiangsu T-Mab
  • JOINN Biologics
  • Lonza
  • Mabplex, and more

Table of Contents

  • Chapter 1: Introduction: Brief history of China Biopharma Service Industry
  • Chapter 2: Legal Framework of CDMO Legislation, including MAH, Government Subsidy Programs and Implications
  • Chapter 3: Innovation in China Biopharma and Outsourcing of Commercial Scale Bioprocessing
  • Chapter 4: Using China-based Biologics CMOs
  • Chapter 5: Directory of China-based Biologics CMOs
  • Chapter 6: Domestic Biologics CMOs vs. MNC Biologics CMOs; strengths and weaknesses
  • Appendix: Biopharmaceutical-devoted CMOs, Companies with Biologics Development and CMO Operations, and Developer companies, Also CMOs

Why this Report

This study will assist Western CMOs, and biopharma developers to make strategic decisions on why and when they should enter the China market.

  • Identify potential clients and partners in China for Western CMOs
  • Analysis for Western mAb developers in partnering with China-based biologics CMOs

 By the Numbers

  • Over 75+ Chinese-owned Contract Manufacturing Organizations, plus up-and-coming facilities!
  • 140+ pages
  • Over 30+ Figures and 20 Tables

Advances in Biopharmaceutical Technology in India

International Biopharma Spotlight

Advances in Biopharmaceutical Technology in India

http://www.simbhq.org/

A Society for Industrial Microbiology and BioPlan Associates co-publication

 

Advances in Biopharmaceutical Technology in India can provide you the most up-to-date news and perspective on events and trends in this rapidly-changing biopharmaceutical industry. Whether you require basic information, or extensive support in partnering with the right companies in India, BioPlan will work with you to meet your needs.

Publication date: January 2008
BioPlan Associates, Inc. and Society for Industrial Microbiology
ISBN: 978-1-934106-07-5

Order Now

  1. Introduction: Biotechnology in India, Dr. P. K. Ghosh President-Biotechnology Cadila Pharmaceuticals Ltd
  2. A Window into India’s Biopharmaceutical Sector, N. Kulkarni, Biospectrum Asia
  3. Indian Biopharmaceutical System and Policies, Yennapu Madhavi, Ph. D, Scientist, National Institute of Science Technology and Development Studies
  4. Government Support for Biotech and Biopharmaceutical Industry, Dr. B. M. Gandhi, CEO, Neo BioMed Services
  5. Biopharmaceutical Products in India, Dr. Scott Wheelwright, Dr. Hazel Aranha, President, Strategic Manufacturing Worldwide, Inc.
  6. Biogeneric Manufacturing in India, Dr. Ashesh Kumar, General Manager M J Biopharm Pvt. Ltd.
  7. Biopharmaceutical Market Situation, Dr. Merlin Goldman President, Magnetical, U.K.
  8. Contract Research Industry in India, Dr. Umakanta Sahoo & Dr. Faiz Kermani, Managing Director, Chiltern International Private Ltd.
  9. Regulatory Landscape for Clinical Trials in India, Dr. Romi Singh, Executive Director, Global Regulatory Affairs, Amgen Inc.
  10. Life Sciences Education in India, Dr. Dipti Sawant Dr. Umakanta Sahoo, Chiltern International Private Ltd.
  11. Vaccines Industry in India, Dr. PS Kulkarni Dr. SS Jadhav, Deputy Medical Director /Executive Director, Serum Institute of India Ltd.
  12. Development of plasma-derived biopharmaceuticals in India: issues and opportunities, Dr. John Curling, President, John Curling, Consulting AB
  13. Bioprocess Technology in India, Dr. David Mousdale, Managing Director Beocarta Ltd., U.K.
  14. Potential Applications of Recent Advances in Immunology to Develop Novel Therapeutic Products in India, Dr. Kumar Shah, President, Endocrine Technology, LLC
  15. Early Stage Key R&D for Successful Development of Protein Products, K. Madduri, Ph.D Dow AgroSciences LLC
  16. Understanding Ayurveda Medicine, Dr. Sampada Mahajan, Chiltern International Private Ltd.
  17. Biopharmaceutical Outsourcing: A comparative Overview of the Landscape in India and China, Minna Damani Editor, CanBiotech
  18. Biopharmaceutical Research Collaboration between Western and Indian Life Science Organizations, Dr. Steve Ferguson, Director, Dr. Uri Reichman, Dr. Bharat Khurana, NIH Office of Technology Transfer
  19. Outsourcing R&D to India, Sajai Singh, Probir Roy J. Sagar Associates
  20. Venture Capital Financing, Sajai Singh Probir Roy Chodhur J. Sagar Associates
  21. Pre Clinical and Clinical Trial in India, V.K.Srinivas, Ph.D, General Manager, R&D, Bharat Biotech International Limited
  22. Outsourcing Biopharma R&D to India, Jim Schnabel, Senior Research Associate, BioPlan Associates, Inc. Technology Transfer: Impact and Importance for Indian Biotechnology Growth, Susan Kling Finston, Founder and Principal, Finston Consulting, LLC

Directory of Top 60 Biopharmaceutical Manufacturers in China

BioPlan’s Directory of Top 60 Biopharmaceutical Manufacturers in China

Completely updated, comprehensive Top 60 Directory provides detailed profiles of China biopharmaceutical facilities: Capacity, history, products, scale, management, business focus, products, R&D, business and partnering strategies, strengths and weaknesses, and future objectives. Highlights upcoming expansions and facilities; key marketed and clinical trial products.

Keep up-to-date as the bio industry expands; stay aware of key participants, new facilities.

A Quick Guide to Clinical Trials

51ESaIWdkVL

 

A Quick Guide to Clinical Trials,  2nd Ed. –  This book provides a unique view of the clinical trial process.

Clinical trials that are well designed and appropriately executed are at the heart of the successful development of all new medicines for patients. Keeping it all straight continues to be challenging. This second edition, edited and written by Dr. Madhu Davies and Dr. Faiz Kermani, has been extensively revised and re-written to include additional topics and new subject matter experts to increase the breadth of discussion of this fascinating discipline. This textbook continues to demystify the topic in an exceptionally reader-friendly, yet authoritative format.

“A Quick Guide to Clinical Trials”, 2nd ed. allows readers, both academic and professional, to get a firm grip on the topic, with just enough detail to ensure a comprehensive understanding. Each chapter also stands alone as a ‘quick dip’ foundation or refresher. The chapters in this book are written by industry experts, carefully chosen for their abilities to clarify complex topics and make them interesting for everyone.

 

News and Announcements

China Biopharma Distributors

NEW! Directory: Top 60 Distributors of Bioprocessing Supplies in China: Opportunities for Global Biopharma Suppliers to Find and Manage Local Distributors in China   Comprehensive China Biopharmaceutical Equipment and Suppliers Distributors Directory 2020 provides detailed profiles of China’s Equipment and Supply Distributors industry. Competitive landscape in China’s bioprocess equipment and consumables segment, with comprehensive information on […]

China CMO

NEW! Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging Opportunities Comprehensive In-depth Study provides detailed analysis of the CMO industry, its recent development and trends. Profiles of China’s Contract Manufacturing Organizations (CMOs) and Contract Development Manufacturing Organizations (CDMOs), including their capacity, history, products, scale, management, business focus, products, R&D, business and […]

Our Team in the News

China Biopharma Distributors

NEW! Directory: Top 60 Distributors of Bioprocessing Supplies in China: Opportunities for Global Biopharma Suppliers to Find and Manage Local Distributors in China   Comprehensive China Biopharmaceutical Equipment and Suppliers Distributors Directory 2020 provides detailed profiles of China’s Equipment and Supply Distributors industry. Competitive landscape in China’s bioprocess equipment and consumables segment, with comprehensive information on […]

China CMO

NEW! Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of … LEARN MORE

China CMO

NEW! Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging … LEARN MORE